Viking Therapeutics Inc (VKTX · NASDAQ)
VKTX · MARKET VIEW
Market view · as of Sep 7, 2026
Revenue (TTM)
$0
0.0% YoY
EPS (latest q)
$-1.10
vs $-1.21 est · beat
52-wk position
61.9%
-17.2% vs 52w high · +1.8% 1mo
Price (last ~year)
Clinical-stage biopharmaceutical firm Viking Therapeutics (VKTX) carries a $4.07 billion market capitalization despite generating no revenue over the trailing twelve months. As of June 30, 2026, the company held $125.8 million in cash against $4.1 million in debt, while reporting an operating loss of $132.6 million for the quarter. Shares have risen 25.7% over the last three months to $34.87, with analyst price targets averaging $92.39.
Valuation
- Market cap
- $4.07B
- PEG
- -0.03
- P/B
- 9.71
- EV/EBITDA
- -71.64
- Beta
- 0.679
- Analyst target
- $92.39
Quality & returns
- Operating margin
- 0.0%
- Profit margin
- 0.0%
- ROE
- -88.8%
- ROA
- -51.9%
Price movement
- Last
- $34.87
- 1-month
- +1.8%
- 3-month
- +25.7%
- RSI (14)
- 55
- vs SMA200
- +4.1%
- 52-wk position
- 61.9% -17.2% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-06-30 | $0 | $-132.6M | $-128.0M | $-127.9M |
| 2026-03-31 | $0 | $-164.1M | $-158.3M | $-158.3M |
| 2025-12-31 | $0 | $-164.7M | $-157.7M | $-157.6M |
| 2025-09-30 | $0 | $-98.6M | $-90.8M | $-90.7M |
Recent news
- Somewhat-Bearish Is Viking Therapeutics (VKTX) Stock Fully Priced After A 411% Run? · 2026-09-04
- Neutral 3 Wall Street Analysts Think Viking Therapeutics Stock Will Roughly Triple Over the Next 12 Months. Here's Why I Think They're Wrong · 2026-09-03
- Neutral Viking Therapeutics to Participate at Upcoming Investor Conferences · 2026-09-02
- Somewhat-Bearish Viking Therapeutics Inc (XTER:1VT) Stock Price, Trades & News · 2026-08-24
- Neutral Viking Therapeutics Inc (XTER:1VT) Stock Earnings Transcripts · 2026-08-24
- Neutral Viking Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference Transcript · 2026-08-24
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)